Publikationen von Claudia Bartels

Zeitschriftenartikel (19)

Foerster, B. R.; Dwamena, B. A.; Petrou, M.; Carlos, R. C.; Callaghan, B. C.; Churchill, C. L.; Mohamed, M. A.; Bartels, C.; Benatar, M.; Bonzano, L. et al.; Ciccarelli, O.; Cosottini, M.; Ellis, C. M.; Ehrenreich, H.; Filippini, N.; Ito, M.; Kalra, S.; Melhem, E. R.; Pyra, T.; Roccatagliata, L.; Senda, J.; Sobue, G.; Turner, M. R.; Feldman, E. L.; Pomper, M. G.: Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: A systematic review and induvidual patient data meta-analysis. Academic Radiology 20 (9), S. 1099 - 1106 (2013)
Wüstenberg, T.; Begemann, M.; Bartels, C.; Gefeller, O.; Stawicki, S.; Hinze-Selch, D.; Mohr, A.; Falkai, P.; Aldenhoff, J. B.; Knauth, M. et al.; Nave, K.-A.; Ehrenreich, H.: Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Molecular Psychiatry 16 (1), S. 26 - 36 (2011)
Wüstenberg, T.; Begemann, M.; Bartels, C.; Gefeller, O.; Stawicki, S.; Hinze-Selch, D.; Mohr, A.; Falkai, P.; Aldenhoff, J.; Knauth, M. et al.; Nave, K. A.; Ehrenreich, H.: EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: indication of areas with most progressive neurodegeneration inherent to the disease process. Molecular Psychiatry 16, 1 (2011)
Bartels, C.; Wegrzyn, M.; Wiedl, A.; Ackermann, V.; Ehrenreich, H.: Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neuroscience 11, 118 (2010)
Ehrenreich, H.; Bartels, C.; Weissenborn, K.; Diener, H.-C.: Response to the letter by Dame. Stroke 41 (3), S. e167 - e168 (2010)
Ehrenreich, H.; Weissenborn, K.; Prange, H.; Schneider, D.; Weimar, C.; Wartenberg, K.; Schellinger, P. D.; Bohn, M.; Becker, H.; Wegrzyn, M. et al.; Jähnig, P.; Herrmann, M.; Knauth, M.; Bähr, M.; Heide, W.; Wagner, A.; Schwab, S.; Reichmann, H.; Schwendemann, G.; Dengler, R.; Kastrup, A.; Bartels, C.: Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40 (12), S. E647 - E656 (2009)
Sirén, A.-L.; Faßhauer, T.; Bartels, C.; Ehrenreich, H.: Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 6 (1), S. 108 - 127 (2009)
Bartels, C.; Mertens, N.; Hofer, S.; Merboldt, K.-D.; Dietrich, J.; Frahm, J.; Ehrenreich, H.: Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system. Neuromuscular Disorders 18, S. 398 - 407 (2008)
Bartels, C.; Späte, K.; Krampe, H.; Ehrenreich, H.: Recombinant human erythropoietin: Novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis. Therapeutic Advances in Neurological Disorders 1, S. 193 - 206 (2008)
Begemann, M.; Sargin, D.; Rossner, M. J.; Bartels, C.; Theis, F.; Wichert, S. P.; Stender, N.; Fischer, B.; Sperling, S.; Stawicki, S. et al.; Wiedl, A.; Falkai, P.; Nave, K.-A.; Ehrenreich, H.: Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Molecular Medicine 14 (9-10), S. 546 - 552 (2008)
Ehrenreich, H.; Bartels, C.; Sargin, D.; Stawicki, S.; Krampe, H.: Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition. Journal of Renal Nutrition 18 (1), S. 146 - 153 (2008)
Krampe, H.; Bartels, C.; Victorson, D.; Enders, C. K.; Beaumont, J.; Cella, D.; Ehrenreich, H.: The influence of personality factors on disease progression and health-related quality of life in people with ALS. Amyotrophic Lateral Sclerosis 9, S. 99 - 107 (2008)
Krampe, H.; Stawicki, S.; Ribbe, K.; Wagner, T.; Bartels, C.; Kroener-Herwig, B.; Ehrenreich, H.: Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes. Journal of Psychiatric Research 43, S. 30 - 47 (2008)
Ehrenreich, H.; Fischer, B.; Norra, C.; Schellenberger, F.; Stender, N.; Stiefel, M.; Sirén, A.-L.; Paulus, W.; Nave, K.-A.; Gold, R. et al.; Bartels, C.: Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130 (10), S. 2577 - 2588 (2007)
Bartels, C.; Kunert, H.-J.; Stawicki, S.; Kroner-Herwig, B.; Ehrenreich, H.; Krampe, H.: Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol and Alcoholism 42 (2), S. 92 - 102 (2007)
Stawicki, S.; Krampe, H.; Niehaus, S.; Ribbe, K.; Wagner, T.; Bartels, C.; Kröner-Herwig, B.; Ehrenreich, H.: Multimodales Monitoring psychotherapeutischer Prozesse in der Behandlung alkoholkranker Patienten. Suchtmedizin in Forschung und Praxis 9 (1), S. 27 - 47 (2007)
Weishaupt, J. H.; Bartels, C.; Pölking, E.; Dietrich, J.; Rohde, G.; Poeggeler, B.; Mertens, N.; Sperling, S.; Bohn, M.; Hüther, G. et al.; Schneider, A.; Bach, A.; Sirén, A.-L.; Hardeland, R.; Bähr, M.; Nave, K.-A.; Ehrenreich, H.: Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. Journal of Pineal Research 41 (4), S. 313 - 323 (2006)
Krampe, H.; Wagner, T.; Stawicki, S.; Bartels, C.; Aust, C.; Kroener-Herwig, B.; Kuefner, H.; Ehrenreich, H.: Personality disorder and chronicity of addiction as independent outcome predictors in alcoholism treatment. Psychiatric Services 57 (5), S. 708 - 712 (2006)
Krampe, H.; Stawicki, S.; Wagner, T.; Bartels, C.; Aust, C.; Rüther, E.; Poser, W.; Ehrenreich, H.: Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: Impact of alcohol deterrents on outcome. Alcoholism-Clinical and Experimental Research 30 (1), S. 86 - 95 (2006)

Buchkapitel (1)

Ehrenreich, H.; Bartels, C.: From bench to bedside: Neuroprotective effects of erythropoietin. In: Recombinant human erythropoietin (rhEPO) in clinical oncology, S. 771 - 792 (Hg. Nowrousian, M.R.). Springer, Wien, New York (2008)
Zur Redakteursansicht